[HTML][HTML] 96. A candidate respiratory syncytial virus (RSV) prefusion F protein investigational vaccine (RSVPreF3 OA) is immunogenic when administered in adults≥ …

TF Schwarz, SJ Hwang, PP Ylisastigui… - Open Forum …, 2022 - ncbi.nlm.nih.gov
96. A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine
(RSVPreF3 OA) Is Immunogenic when Administered in Adults ≥ 60 Years of Age: Results at 6 …

A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine (RSVPreF3 OA) Is Immunogenic when Administered in Adults≥ 60 Years …

T Schwarz, S Hwang, P Ylisastigui, C Liu… - …, 2023 - thieme-connect.com
Objectives Respiratory Syncytial Virus (RSV) infections are frequent and can lead to
respiratory complications in older adults (OA). However, there is no licensed RSV vaccine …

96. A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine (RSVPreF3 OA) Is Immunogenic when Administered in Adults≥ 60 …

Open Forum Infectious Diseases, 2022 - europepmc.org
Background RSV infections are frequent and can lead to respiratory complications in older
adults (OA). However, there is no licensed RSV vaccine yet. Here we present …

96. A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine (RSVPreF3 OA) Is Immunogenic when Administered in Adults≥ 60 …

TF Schwarz, SJ Hwang, PP Ylisastigui… - Open Forum …, 2022 - academic.oup.com
Background RSV infections are frequent and can lead to respiratory complications in older
adults (OA). However, there is no licensed RSV vaccine yet. Here we present …

96. A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine (RSVPreF3 OA) Is Immunogenic when Administered in Adults≥ 60 …

TF Schwarz, SJ Hwang, PP Ylisastigui… - Open Forum …, 2022 - academic.oup.com
Background RSV infections are frequent and can lead to respiratory complications in older
adults (OA). However, there is no licensed RSV vaccine yet. Here we present …